CLINICAL_TRIALS
trial_result
· 2025-08-29
Clinical Trial Update: Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis [Phase 2]
Summary
Phase 2 trial results report long-term safety and side effects of ruxolitinib in patients with myelofibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2025-08-29